The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PF-07104091 as a Single Agent and in Combination Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access to Trilaciclib for Patients Receiving Chemotherapy for Small Cell Lung Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Gimatecan (ST1481) in Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.
- Status
- UNKNOWN
- Phase
- PHASE3
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Effect of Hyponatremia in Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
IMP4297 in Combination With Temozolomide in Patients With Advanced Solid Tumors and Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PLM60 in Subjects With Relapsed Small-cell Lung Cancer After Platinum-based First-Line Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Anlotinib In Combination With Durvalumab As Sequential Therapy of Thoracic Radiotherapy After Induction Chemotherapy For Extensive-Stage Small Cell Lung Cancer:A Single Arm Study
- Status
- UNKNOWN
- Phase
- PHASE2
A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2